Dublin, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/p94d7f/nerve_repair_and)
has announced the addition of the
"Nerve Repair & Regeneration Market by Xenografts,
Neuromodulation, External & Surgery - Global Trend &
Forecast to 2018" report to their offering.
The nerve repair and regeneration market was worth $4.1 billion in
2012 and is expected to grow at a CAGR of 11.5% in the next five
years, primarily due to technological advancements and favorable
reimbursement policies. The market is expected to witness a high
growth in nerve grafting and neuromodulation segments, as they
offer effective solutions for peripheral nerve repair and chronic
pain, incontinence, heart failure, headache, depression, and
epilepsy.
Moreover, there are certain devices in clinical trials for newer
applications; for instance, deep brain stimulation for Alzheimer's
and depression, and vagus nerve stimulation for heart failure.
Novel therapies (such as stem cell therapy) and emerging markets
provide huge growth opportunities. However, the major challenges
faced by the industry are donor site morbidity and inadequate nerve
regeneration by conduits. The neuromodulation market is expected to
reach $7.8 billion by 2018.
A number of factors such as the rapidly aging population, growing
number of peripheral nerve injuries and associated diseases like
Alzheimer's, epilepsy, and Parkinson's are the major reasons for
the growth of this market. According to a recent study, around 87%
of peripheral nerve injuries are resulted from trauma; the U.S.
accounts for around 40% of the global peripheral
nerve repair surgeries. According to the International
Neurostimulation Society, about 40 million to 50 million patients
worldwide suffer from epilepsy and 1.5 million people suffer from
Parkinson's in the U.S. alone. Moreover, treatment for tinnitus
represents one of the emerging applications in this market.
According to the American Tinnitus Association, about 50 million
people suffer from this disease in the U.S. alone.
Scope of the Report
Surgery:
- Direct Neurorraphy
- Perineural repair
- Epineural repair
- Group Fascicular Repair
- Nerve Grafting
- Autografts
- Allografts
- Xenografts
- Stem cell therapy
- Neurostimulation/Neuromodulation surgery
Products:
Biomaterials:
- Nerve Conduits
- Nerve Protectors
- Nerve Wraps
- Nerve Connectors
Neurostimulation/Neuromodulation:
- Internal Neurostimulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Electrical Stimulation
- External Neurostimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
Geography:
- North America
- Europe
- Asia
- ROW (Africa, LATAM, Middle-East, andPacific countries)
Key Topics Covered
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Nerve Repair And Regeneration Market
5 Geographic Analysis
6 Competitive Landscape
7 Company Profiles (Overview, Financials, Products & Services,
Strategy, & Developments)
Companies Mentioned
- Alafair Biosciences
- Axogen
- Baxter International
- Biocontrol Medical
- Boston Scientific Corporation
- Cyberonics
- Integra Lifesciences Holdings Corp
- Medtronic
- Orthomed
- Polyganics
- Salumedica
- St Jude Medical
- Stryker Corporation
For more information visit http://www.researchandmarkets.com/research/p94d7f/nerve_repair_and
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: